AI Accelerator Grant Program Service

The issuing agency is seeking a vendor to provide an artificial intelligence accelerator grant program service. This program supports international, AI-driven ovarian cancer research collaborations focused on improving prevention, early detection, treatment response, and patient outcomes. The initiative enables large-scale, data-intensive biomedical research using artificial intelligence, computational science, and clinical collaboration. The scope of work covers applying artificial intelligence to ovarian cancer biology, diagnosis, and treatment. Specific research areas include cancer prevention and initiation mechanisms, early detection and screening technologies, and tumor microenvironment and cancer ecosystem modeling. The project also encompasses treatment resistance and recurrence prediction, patient stratification and risk prediction models, medical imaging analysis using AI, biomarker discovery and validation, and AI-driven literature synthesis and evidence analysis. Eligibility is restricted to onshore organizations based in the United States. The agency requires the performance of the work to be conducted offsite. The agency is currently looking for proposals to determine the budget, and the source document does not specify further evaluation criteria or key dates.